mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
4e-05 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-05 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
8e-05 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
8e-05 |